Coripharma sell "Ponatinib"
Basic Information
1.2K
76
7
4.4(43)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Ponatinib
Details
Substance
Manufacturer(s)
Specifications
- CAS Number: 943319-70-8
- Chemical Formula: C29H27F3N6O
- Dosage Form: Film-coated tablets in 15 mg, 30 mg and 45 mg strengths
- IUPAC Name: 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide
- EC Number: 851-222-7
- Molecular Weight: 532.6
- Indication: Treatment of leukemia (generic ponatinib)
- Content Uniformity: Controlled to ensure consistent content uniformity across the 15 mg, 30 mg and 45 mg tablet strengths
Other Information
Additional Description:
Ponatinib FC tablets, available in 15 mg, 30 mg and 45 mg strengths, treat leukemia. The pivotal bioequivalence study has passed, with the dossier expected in Q1 2026 and a DCP slot requested for May 2026. Coripharma's generic version is being developed at its R&D facility in Iceland, powered entirely by sustainable energy, with its business development team available to discuss opportunities.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment